Management Of Anaphylaxis

This podcast addresses the critical care management of anaphylaxis, featuring Dr. Guha Krishnaswamy, an expert in Pulmonary Critical Care, Allergy, Immunology, and Infectious Diseases. The discussion covers the definition and classification of anaphylaxis, emphasizing the importance of early epinephrine administration and the recognition of severe symptoms like bowel/bladder incontinence and altered cognition. Risk factors such as the use of ACE inhibitors and beta blockers are highlighted, along with the increasing global incidence of anaphylaxis due to new drugs and therapies. The podcast further explores diagnostic criteria, including the role of tryptase levels, and delves into various treatment options, including glucagon, Sugammadex, vasopressin, and methylene blue for refractory cases, stressing the need for tailored post-ICU management and patient education.

Outlines

Part 1: Introduction, Definitions, and Classification

Part 2: Epidemiology and Risk Factors

Part 3: Clinical Diagnosis and Mechanisms

Part 4: Acute Management and Treatment Protocols

Part 5: Advanced Interventions for Refractory Cases

Part 6: Post-ICU Care and Patient Education

Part 7: Personal Reflections and Closing

Sign in to continue reading, translating and more.

Continue

Critical Matters

Part 1: Introduction, Definitions, and Classification

Introduction to Anaphylaxis Management in Critical Care

Defining Anaphylaxis: Acute Onset, Systemic Involvement, and Mast Cell Mediators

Classifying Anaphylaxis: Severity, Phases, and the Risk of Biphasic Reactions

Part 2: Epidemiology and Risk Factors

The Importance of Early Epinephrine and Risk Factors for Severe Anaphylaxis

Epidemiology of Anaphylaxis: Increasing Incidence, Prevalence, and Mortality

Risk Factors for Severe Anaphylaxis: Allergen Type, Medications, and Cardiopulmonary Disease

Part 3: Clinical Diagnosis and Mechanisms

Emphasizing Early Epinephrine and Diagnostic Considerations in Anaphylaxis

Diagnostic Criteria and Endotypes/Phenotypes of Anaphylaxis

IgG-Mediated, Bradykinin-Mediated, and Cytokine-Mediated Anaphylaxis

Differential Diagnosis and Perioperative Anaphylaxis

Diagnostic Tests: Tryptase Levels and Hereditary Alpha Tryptosemia (HATS)

Part 4: Acute Management and Treatment Protocols

Post-ICU Diagnosis and the Importance of Epinephrine

Epinephrine Administration: Dosage, Route, and Considerations

Oxygen, Airway Management, and the Dangers of Upright Posture in Hypovolemic Patients

Steroids, Antihistamines, and Refractory Anaphylaxis

Part 5: Advanced Interventions for Refractory Cases

Managing Refractory Anaphylaxis: Glucagon, IV Pressors, and Vasopressin

Salvage Therapies: Methylene Blue and ECMO

Anaphylactic Reactions to TPA and the Importance of Stopping the Offending Drug

Part 6: Post-ICU Care and Patient Education

Post-ICU Management: Education, Anaphylaxis Management Plan, and Allergy Referral

EpiPen Education, Steroid Tapers, and Follow-Up

Part 7: Personal Reflections and Closing

Books That Have Influenced Dr. Krishnaswamy

Empathy vs. Compassion and the Web of Life

Closing Remarks

Management Of Anaphylaxis

Critical Matters

Part 1: Introduction, Definitions, and Classification

00:05Introduction to Anaphylaxis Management in Critical Care

Introduction to Anaphylaxis Management in Critical Care

02:08Defining Anaphylaxis: Acute Onset, Systemic Involvement, and Mast Cell Mediators

Defining Anaphylaxis: Acute Onset, Systemic Involvement, and Mast Cell Mediators

04:21Classifying Anaphylaxis: Severity, Phases, and the Risk of Biphasic Reactions

Classifying Anaphylaxis: Severity, Phases, and the Risk of Biphasic Reactions

Part 2: Epidemiology and Risk Factors

08:29The Importance of Early Epinephrine and Risk Factors for Severe Anaphylaxis

The Importance of Early Epinephrine and Risk Factors for Severe Anaphylaxis

11:50Epidemiology of Anaphylaxis: Increasing Incidence, Prevalence, and Mortality

Epidemiology of Anaphylaxis: Increasing Incidence, Prevalence, and Mortality

14:49Risk Factors for Severe Anaphylaxis: Allergen Type, Medications, and Cardiopulmonary Disease

Risk Factors for Severe Anaphylaxis: Allergen Type, Medications, and Cardiopulmonary Disease

Part 3: Clinical Diagnosis and Mechanisms

20:28Emphasizing Early Epinephrine and Diagnostic Considerations in Anaphylaxis

Emphasizing Early Epinephrine and Diagnostic Considerations in Anaphylaxis

23:33Diagnostic Criteria and Endotypes/Phenotypes of Anaphylaxis

Diagnostic Criteria and Endotypes/Phenotypes of Anaphylaxis

25:37IgG-Mediated, Bradykinin-Mediated, and Cytokine-Mediated Anaphylaxis

IgG-Mediated, Bradykinin-Mediated, and Cytokine-Mediated Anaphylaxis

30:47Differential Diagnosis and Perioperative Anaphylaxis

Differential Diagnosis and Perioperative Anaphylaxis

33:31Diagnostic Tests: Tryptase Levels and Hereditary Alpha Tryptosemia (HATS)

Diagnostic Tests: Tryptase Levels and Hereditary Alpha Tryptosemia (HATS)

Part 4: Acute Management and Treatment Protocols

37:55Post-ICU Diagnosis and the Importance of Epinephrine

Post-ICU Diagnosis and the Importance of Epinephrine

40:02Epinephrine Administration: Dosage, Route, and Considerations

Epinephrine Administration: Dosage, Route, and Considerations

44:38Oxygen, Airway Management, and the Dangers of Upright Posture in Hypovolemic Patients

Oxygen, Airway Management, and the Dangers of Upright Posture in Hypovolemic Patients

49:47Steroids, Antihistamines, and Refractory Anaphylaxis

Steroids, Antihistamines, and Refractory Anaphylaxis

Part 5: Advanced Interventions for Refractory Cases

53:10Managing Refractory Anaphylaxis: Glucagon, IV Pressors, and Vasopressin

Managing Refractory Anaphylaxis: Glucagon, IV Pressors, and Vasopressin

58:21Salvage Therapies: Methylene Blue and ECMO

Salvage Therapies: Methylene Blue and ECMO

1:01:08Anaphylactic Reactions to TPA and the Importance of Stopping the Offending Drug

Anaphylactic Reactions to TPA and the Importance of Stopping the Offending Drug

Part 6: Post-ICU Care and Patient Education

1:04:22Post-ICU Management: Education, Anaphylaxis Management Plan, and Allergy Referral

Post-ICU Management: Education, Anaphylaxis Management Plan, and Allergy Referral

1:07:39EpiPen Education, Steroid Tapers, and Follow-Up

EpiPen Education, Steroid Tapers, and Follow-Up

Part 7: Personal Reflections and Closing

1:10:39Books That Have Influenced Dr. Krishnaswamy

Books That Have Influenced Dr. Krishnaswamy

1:13:21Empathy vs. Compassion and the Web of Life

Empathy vs. Compassion and the Web of Life

1:19:02Closing Remarks

Closing Remarks